Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled trial of FOL-005 for scalp hair growth
2017-003809-17Phase 2Completed
- Sponsor
- Follicum
- Start
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Follicopeptide in androgenetic alopecia (AGA), alopecia areata, sponsored by Follicum. Started Nov 2017; status: completed.
02
Drugs
Follicopeptide
03
Conditions
androgenetic alopecia (AGA)alopecia areata
Beyond the preview
Go deeper on 2017-003809-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003809-17.